Introduction to ARISE 2023
The ARISE Consensus Roundtable will bring together all 3 stakeholders in brain aneurysm, chronic subdural hematoma and brain arteriovenous malformation research and practice: academia (leading international physicians/scientists from all involved disciplines), industry (scientists and executives from private sector pharmaceutical, device and imaging companies), and regulatory institutions (executive managers, physicians and scientists from government agencies). The aim of the Roundtable is to advance and accelerate stroke research to ultimately result in improved acute stroke treatment, care, and prevention. To achieve this goal, ARISE will:
WHY ATTEND
The overarching aim of the Aneurysm/AVM/cSDH Roundtable Discussion with Industry and Stroke Experts (ARISE) is to create a multidisciplinary platform that can allow collaborations of public and private sector experts to share their knowledge and achieve consensus on strategies intended to improve stroke prevention approaches through advances in research studies and clinical practice. ARISE will include a broad multidisciplinary collaboration as the primary clinical disciplines involved in stroke prevention and care efforts and include neurosurgeons, neuroendovascular surgeons, neurointerventional radiologist and neurologists.
LEARN MORE